搜尋結果
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
CNBC· 11 小時前Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a ...
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters· 12 小時前, opens new tab and other drugmakers to stop more than 70,000 lawsuits in Delaware over ...
Spain starts closing Franco sympathisers' foundation
Reuters· 12 小時前Spain's government has begun closing down the Francisco Franco foundation, a non-profit ...
Germany to order 105 Leopard tanks to equip German brigade in Lithuania
Reuters· 12 小時前Germany plans to order 105 Leopard 2 A8 tanks from armsmaker KNDS for 2.93 billion euros ($3.14 ...
PayPal Ventures leads $20M round into Gynger, which offers companies 'buy now, pay ...
TechCrunch· 12 小時前Gynger, a platform that lends capital to companies for technology purchases, has raised $20 ...
More states expected to roll out Inflation Reduction Act energy-efficiency rebates this summer
CNBC· 13 小時前New York is launching a program offering homeowners up to $14,000 in total rebates for ...
Germany Bolsters Military Expansion With €2.9 Billion Tank Order
Bloomberg· 13 小時前Have a confidential tip for our reporters? Germany plans to buy 105 additional Leopard 2 A8 ...
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters· 14 小時前, opens new tab said on Thursday a late-stage study showed its injectable drug, lenacapavir, ...
Sberbank's profits may hit new record as sanctions cull competition
Reuters· 14 小時前, opens new tab expects to send at least $11.6 billion in tax and dividends to Russia's ...
U.S. crude oil trades above $82 per barrel, on pace for second weekly gain in a row
CNBC· 14 小時前U.S. crude rose Thursday to trade above $82 per barrel, with the benchmark heading for its ...